Archive: 12/11/2011
Novel experimental agent is highly active in CLL patients, interim study shows
An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other ...
Cancer
Dec 11, 2011 |
3.5 / 5 (2) |
0
B cell receptor inhibitor causes chronic lymphocytic leukemia remission
A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting ...
Cancer
Dec 11, 2011 |
5 / 5 (2) |
0
Scar findings could lead to new therapies
Researchers at the Stanford University School of Medicine report that they have identified the molecular pathway through which physical force contributes to scarring in mice.
Medical research
Dec 11, 2011 |
5 / 5 (6) |
1
|
Rare genetic disorder provides clues to development of the pancreas
A rare genetic disorder has given researchers at the University of Exeter a surprising insight into how the pancreas develops. The finding provides a clue to how it may be possible to 'programme' stem cells – master ...
Genetics
Dec 11, 2011 |
4.5 / 5 (2) |
0
|
How patients will respond to immunomodulator therapy for multiple myeloma
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of ...
Cancer
Dec 11, 2011 |
5 / 5 (1) |
0
In Iraq war, a revolution in battlefield medicine
The Iraq war ushered in dramatic advances in battlefield medicine, with the effects of homemade bombs leading the US military to radically change how it treats wounded soldiers.
Other
Dec 11, 2011 |
4.3 / 5 (3) |
0
New method boosts blood-clotting for hemophiliacs
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children's Research Hospital in Memphis and demonstrated ...
Diseases, Conditions, Syndromes
Dec 11, 2011 |
not rated yet |
0
|
